Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) Gross Margin (2024 - 2025)

Nuvation Bio (NUVB) has disclosed Gross Margin for 2 consecutive years, with 117.11% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin rose 9093.0% to 117.11% in Q4 2025 year-over-year; TTM through Dec 2025 was 98.64%, a 8854.0% increase, with the full-year FY2025 number at 98.64%, up 8854.0% from a year prior.
  • Gross Margin was 117.11% for Q4 2025 at Nuvation Bio, up from 74.47% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 117.11% in Q4 2025 to a low of 108.39% in Q3 2024.